J&J Investment of $2B Boosts US Drug Manufacturing Capacity
Johnson & Johnson, an industry leader known for its global healthcare innovation, unveiled plans to increase its presence in the state of North Carolina...
Pharmaceutical Tariff Agreed at 15% Under US-EU Trade Deal
Pharmaceutical tariffs between the European Union and the United States will now be limited at 15% under the terms of the latest trade agreement,...
The U.S. FDA Approved Papzimeos for RRP Treatment in Adults
The U.S. Food and Drug Administration granted approval for Papzimeos (zopapogene imadenovec-drba), marking the introduction of a first-of-its-kind, non-replicating adenoviral vector-based immunotherapy for adult...
Trump Signs Executive Order to Boost US Pharma Supply Chain
US President Donald Trump has instructed the Department of Health and Human Services (HHS) to compile a list of essential medicines and ensure the...
Lupin, Sandoz Collab to Commercialise Biosimilar Ranibizumab
Lupin partners with Sandoz Group AG to commercialise and market its biosimilar ranibizumab worldwide. The product will be commercialised in a number of markets,...
FDA Approves Brinsupri by Insmed for Chronic Lung Condition
The U.S. Food and Drug Administration, FDA approves Brinsupri, Insmed's oral drug for a lung disease, the company announced. This marks the first treatment...
FDA PreCheck Programme to Boost U.S. Drug Manufacturing
The Food and Drug Administration has launched a new initiative aimed at boosting drug manufacturing within the United States. This move follows a directive...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...